Analyst
Wolfe Research
Equibles does not estimate personal net worth.
Michael Polark is recorded as Analyst at Wolfe Research. Michael Polark has spoken on 23 earnings calls and 1 other investor event across 11 companies, most recently for Mobia Medical, Inc. on August 14, 2026. Those appearances were for Dexcom Inc (DXCM), Insulet Corp (PODD), STERIS plc (STE), Sotera Health Co (SHC), Boston Scientific Corp (BSX) and 6 other companies. The companies whose calls Michael Polark spoke on are classified in the Healthcare sector.
“Modeling question for the back half, piggybacking on Ryan's question there. So, in the quarter, I think you added five active territories quarter over quarter. My question on that metric is, how are you building the back half?”
“Dan, I wanted to ask on or come back to AST. You referenced inventory destocking. Is trajectory of volume growth just how you budgeted this year?”
“Jumping around calls, so if you commented already on litigation, I apologize for this question. But can we get a brief litigation update? I see New Mexico, which was always one of the smaller items on EO, settled in early July.”
“I hear all the updates on capacity expansion. Appreciate that. As I look at the updated cardiopulmonary guide, what's implied for growth in the second half, you know, 7%-ish in 3Q, 4Q after, you know, low doubles in the first half.”
“Jake, at the beginning of your prepared remark, you noted product performance was excellent in the quarter.”
Wolfe Research
Analyst
Source not stated
DXCM
Medical Devices · Healthcare
PODD
Medical Devices · Healthcare
STE
Medical Devices · Healthcare
SHC
Diagnostics & Research · Healthcare
RGEN
Medical Instruments & Supplies · Healthcare
Medical Instruments & Supplies · Healthcare
EMBC
Medical Instruments & Supplies · Healthcare
MOBI
Medical Devices · Healthcare
LIVN
Medical Devices · Healthcare
NPCE
Medical Devices · Healthcare
